Blog Post
The Netherlands: specific exemption notification for medical devices in case of a no-deal Brexit
08 April 2019
Petra den Boer
AssociateAmsterdam
Email petra.denboer@hoganlovells.com
Phone +31 20 55 33 757
Fax +31 20 55 33 777
LanguagesEnglish, Dutch
Practice groupGlobal Regulatory
As part of the Global Regulatory Life Sciences team, Petra den Boer advises on draft contracts, and litigates in cases related to pharmaceutical products, medicial devices and food.
Such advice includes legal advice for international and national pharmaceutical companies on matters relating to advertising and sponsoring, parallel trade, labelling and clinical trials.
Education and admissions
Education
Bachelor's degree in Dutch Law, Erasmus University Rotterdam
Master's degree in Employment Law, Erasmus University Rotterdam
Latest thinking and events
Blog Post
Update EMA relocation to Amsterdam & regulatory changes for EU centrally approved medicinal products
12 February 2019
Blog Post
EMA office in Amsterdam opened – Wooden shoes, orphan drugs and drug pricing in the context of Brexit
11 January 2019
Press Releases
Hogan Lovells advises Daimler on a mobility joint venture with BMW
28 March 2018
Hogan Lovells Publications
Pharmaceutical pricing key priority for Dutch Competition Authority in 2018-2019
16 February 2018
